.png)
.png)
.jpg "Angela P. Campbell, MD, MPH photo")
Medical Officer
Centers for Disease Control and Prevention
Disclosure(s): No financial relationships to disclose
Dr. Campbell is a Medical Officer and Team Lead for the Severe Illness and Multisystem Inflammatory Syndrome Team in the COVID and Other Respiratory Viruses Division (proposed) in CDC’s National Center for Immunization and Respiratory Diseases. Dr. Campbell completed her medical degree at Vanderbilt University. She trained in pediatrics and pediatric infectious diseases, and completed an MPH, at the University of Washington. Dr. Campbell first worked at CDC as an EIS officer, followed by several years in academic medicine in Seattle studying respiratory viruses in immunocompromised patients, before rejoining CDC in 2013. In the Influenza Division, Dr. Campbell’s work focused on antiviral treatment and antiviral effectiveness, vaccine effectiveness, pandemic preparedness, and development of CDC clinical guidance related to treatment and prevention of seasonal and novel influenza viruses. Since 2020, she has been actively involved in CDC’s pandemic response to the COVID-19 pandemic, and she currently leads a team with a particular focus on epidemiologic studies related to complications of COVID-19 in children, including multisystem inflammatory syndrome (MIS), vaccine effectiveness of COVID-19 vaccines against COVID-19 pediatric hospitalizations and MIS-C, and severe respiratory syncytial virus (RSV) in critically ill infants. Dr. Campbell is an Adjunct Associate Professor of Pediatrics at Emory University School of Medicine, and has a Professional Staff appointment at Children’s Healthcare of Atlanta where she cares for patients as an attending on the Infectious Diseases service and as a Pediatric Hospitalist.